Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Leuprorelin acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg powder for injection solution + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 11.25mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 7.5mg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 22.5mg injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 30mg/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 11.25mg powder for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 15mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 5mg/mL injection solution 0.2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 65mg implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg powder for injection solution + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 11.25mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 3.75mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 45mg powder for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprolide acetate 15mg powder for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 20 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 20 mg/mL suspension for injection |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 3.75 mg powder for suspension for injection syringe |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 3.75 mg powder for suspension for injection syringe |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin acetate 30 mg powder for prolonged-release suspension for injection syringe |
Has basis of strength substance (attribute) |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant |
Has precise active ingredient |
True |
Leuprorelin acetate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |